An update on drugs for the treatment of menopausal symptoms

The 2012 Hormone Therapy Position Statement of The North American Menopause Society

(2016)   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

A 12-week treatment with fractional CO2laser for vulvovaginal atrophy: a pilot study

(2014) S. Salvatore et al.   CLIMACTERIC

Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause

(2014) R. E. Nappi et al.   CLIMACTERIC

Position of the Spanish Menopause Society regarding vaginal health care in postmenopausal women

(2014) Rafael Sánchez-Borrego et al.   MATURITAS

Genitourinary syndrome of menopause

(2014) David J. Portman et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Vaginal Estrogen for Genitourinary Syndrome of Menopause

(2014) David D. Rahn et al.   OBSTETRICS AND GYNECOLOGY

Ospemifene for the Treatment of Vulvovaginal Atrophy and Dyspareunia in Postmenopausal Women

(2014) Amber N. McLendon et al.   PHARMACOTHERAPY

Global Consensus Statement on Menopausal Hormone Therapy

(2013) T. J. de Villiers et al.   CLIMACTERIC

Incidence of genitourinary conditions in women with a diagnosis of vulvar/vaginal atrophy

(2013) Ginger D. Constantine et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms – comments on major statements of the Cochrane Collaboration report 2012 “black cohosh (Cimicifugaspp.) for menopausal symptoms (review)”

(2013) André-M. Beer et al.   GYNECOLOGICAL ENDOCRINOLOGY

Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms

(2013) James A. Simon et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy

(2013) David J. Portman et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Management of symptomatic vulvovaginal atrophy

(2013)   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Intravaginal Practices and Risk of Bacterial Vaginosis and Candidiasis Infection Among a Cohort of Women in the United States

(2013) Joelle M. Brown et al.   OBSTETRICS AND GYNECOLOGY

Hot flush symptom-free days with bazedoxifene/conjugated estrogens in postmenopausal women

(2012) H. Yu et al.   CLIMACTERIC

What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone

(2012) J. A. Simon   CLIMACTERIC

Androgen receptor expression in the human vagina under different physiological and treatment conditions

(2012) M Baldassarre et al.   INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH

The pros and cons of plant estrogens for menopause

(2012) Sarah Bedell et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

The pollen extract Femal—a nonestrogenic alternative to hormone therapy in women with menopausal symptoms

(2012) Ann-Cathrin Hellström et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia

(2011) F. Labrie et al.   CLIMACTERIC

Menopausal hot flushes and night sweats: where are we now?

(2011) D. F. Archer et al.   CLIMACTERIC

Nonestrogenic Management of Hot Flashes

(2011) Charles L. Loprinzi et al.   JOURNAL OF CLINICAL ONCOLOGY

Topical Testosterone for Breast Cancer Patients with Vaginal Atrophy Related to Aromatase Inhibitors: A Phase I/II Study

(2011) S. Witherby et al.   ONCOLOGIST

Age of menopause and impact of climacteric symptoms by geographical region

(2010) S. Palacios et al.   CLIMACTERIC

Minimized estradiol absorption with ultra-low-dose 10 μg 17β-estradiol vaginal tablets

(2010) M. Eugster-Hausmann et al.   CLIMACTERIC

Recommendations for the management of postmenopausal vaginal atrophy

(2010) D. W. Sturdee et al.   CLIMACTERIC

Consensus Recommendations on the Use of an Erbium-Doped 1,550-nm Fractionated Laser and Its Applications in Dermatologic Laser Surgery

(2010) Michael Sherling et al.   DERMATOLOGIC SURGERY

A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women

(2010) Risa Kagan et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview

(2009) O. Al-Baghdadi et al.   CLIMACTERIC

Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile

(2009) Rogerio A. Lobo et al.   FERTILITY AND STERILITY

Vaginal Estrogen Therapy for the Treatment of Atrophic Vaginitis

(2009) Catherine Lynch   JOURNAL OF WOMENS HEALTH

Menopause and sexuality: Prevalence of symptoms and impact on quality of life

(2009) Rossella E. Nappi et al.   MATURITAS

Managing urogenital atrophy

(2009) Santiago Palacios   MATURITAS

Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women

(2009) Fernand Labrie et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Revisiting the Duration of Vasomotor Symptoms of Menopause: A Meta-Analysis

(2008) Mary C. Politi et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women

(2008) Fernand Labrie et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Impaired quality of life among middle aged women: A multicentre Latin American study

(2008) Peter Chedraui et al.   MATURITAS